ADVIA: CENTAUR AND ACS: 180 CPSA ASSAY

Prostate-specific Antigen (psa) For Management Of Prostate Cancers

BAYER CORP.

The following data is part of a premarket notification filed by Bayer Corp. with the FDA for Advia: Centaur And Acs: 180 Cpsa Assay.

Pre-market Notification Details

Device IDK002376
510k NumberK002376
Device Name:ADVIA: CENTAUR AND ACS: 180 CPSA ASSAY
ClassificationProstate-specific Antigen (psa) For Management Of Prostate Cancers
Applicant BAYER CORP. 63 NORTH ST. Medfield,  MA  02052 -1688
ContactWilliam J Pignato
CorrespondentWilliam J Pignato
BAYER CORP. 63 NORTH ST. Medfield,  MA  02052 -1688
Product CodeLTJ  
CFR Regulation Number866.6010 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received2000-08-04
Decision Date2000-10-26

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.